Video Material
"What does ITM mean to you?"
As part of our 20th anniversary campaign, we asked our colleagues: 'What does ITM mean to you?' Watch the video to discover more about our unique culture and meaningful purpose as we shape the future of radiopharmaceuticals together.
Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives
Tune In! Our CEO Andrew Cavey recently joined Dr Oliver Sartor on the podcast “Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives”, hosted by UroToday. Together, they dive into the evolving role of radiopharmaceuticals in advancing cancer treatment and explore the potential future pathways for our industry.
This thought-provoking conversation is now available to stream for free on UroToday + GU OncToday’s website – an insightful listen for anyone interested in the latest innovations in radiopharmaceuticals.
Celebrating 20 Years of ITM: From Startup to Global Leader in Radiopharmaceuticals
For 20 years, ITM has evolved from a startup in Garching, near Munich, to a global leader in radiopharmaceuticals, pioneering innovative targeted treatments to improve cancer treatments. Our journey reflects a commitment to precision medicine and better patient outcomes worldwide. We’re excited to share our story of ITM’s 20 year journey with you in a video.
Come celebrate with us by visiting our 20th Anniversary Microsite.
New Isotope Production System at Bruce Power Successfully Produces First Medical Isotope
An international collaboration between ITM, Bruce Power and Isogen (a Kinectrics and Framatome company), announced a milestone marking the first instance lutetium-177, a short-lived medical isotope, has been produced in a commercial nuclear power reactor.
ITM Virtual Tour
Watch our virtual tour for an impression of ITM, our sites and our daily work.
ITM's Satellite Symposium at virtual EANM Congress 2020
ITM's highly scientific Satellite Symposium “Challenges and Innovative Approaches in the Management of Osteoblastic Metastatic Disease” at virtual EANM Congress 2020 was a great success.
ITM. Who we are and what we do.
See our image video and learn about Targeted Radionuclide Diagniostics and Therapies in Precision Oncology.
ITM Virtual Radiotheranostics Symposium at ENETS 2020
ITM's highly scientific Radiotheranostics Satellite Symposium “Novel Approaches to Optimizing Targeted Radionuclide Therapy in Neuroendocrine Neoplasms” at ENETS 2020 was a great success. Here a short compilation.
Radiotheranostics Satellite Symposium
Prof M Caplin, Prof P Ruszniewski, Dr G Nicolas and Dr S Glasberg discussed about “Towards Optimizing the Application of Radiotheranostics in the Management of NET Patients” at ENETS 2019.
Targeted Radionuclide Therapy for Cancer Treatment.
PRRT as treatment option for cancers like neuroendocrine tumors. See a practicing physician and two patients talking about their experience.
YouTube Video
Lutetium Production
YouTube Video
Targeted Radionuclide Therapy